Captopril
The first orally active ACE inhibitor, used to treat hypertension, heart failure, and to protect kidney function in diabetic nephropathy. By blocking the angiotensin-converting enzyme, it prevents the formation of angiotensin II, leading to blood vessel relaxation and reduced aldosterone secretion. A dry persistent cough is a characteristic and common side effect.
Молекулярная масса
217,2850 g/mol
LogP
0,30
TPSA
58,60 Ų
Правило пяти Липинского
Соответствует
Терапевтические области
Классы препаратов
Механизм действия
First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.
2D Структура
Cite this structure
Embed this structure
SMILES
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
InChI
InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1
Molecular Formula
C9H15NO3S
HBD / HBA
2 / 4
Вращаемые Связи
3
Тяжёлые Атомы
14
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Часто задаваемые вопросы
The first orally active ACE inhibitor, used to treat hypertension, heart failure, and to protect kidney function in diabetic nephropathy. By blocking the angiotensin-converting enzyme, it prevents the formation of angiotensin II, leading to blood vessel relaxation and reduced aldosterone secretion. A dry persistent cough is a characteristic and common side effect.
First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.
Key pharmacokinetic parameters for Captopril: Half-life: 1.9 hours.
Yes, Captopril is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
Related Drugs
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1560. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 44093. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="captopril"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/captopril/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/captopril/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/captopril/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="captopril"></drugfyi-drug>